Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ypeginterferon Alfa-2b in Chinese Chronic Hepatitis B Patients
NCT01760122Phase 3Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Mar 2013; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01760122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760122.